Technology
Health
Pharmaceutical

SIGA Technologies

$5.44
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.24 (-4.23%) Today
$0.00 (0.00%) As of 4:02 PM EDT after-hours

Why Robinhood?

You can buy or sell SIGA and other stocks, options, ETFs, and crypto commission-free!

About SIGA

SIGA Technologies, Inc. engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The company develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other dangerous viruses. Read More It offers an orally administered antiviral drug that targets orthopoxviruses under the TPOXX brand. The company was founded on December 28, 1995 and is headquartered in New York, NY.

Employees
41
Headquarters
New York, New York
Founded
1995
Market Cap
440.32M
Price-Earnings Ratio
1.04
Dividend Yield
0.00
Average Volume
148.97K
High Today
$5.82
Low Today
$5.43
Open Price
$5.68
Volume
124.11K
52 Week High
$8.47
52 Week Low
$4.68

Collections

Technology
Health
Pharmaceutical
Medical
US
North America

SIGA Earnings

Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 6, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.